These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes. Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131 [TBL] [Abstract][Full Text] [Related]
49. Detection of immunotoxicity using T-cell based cytokine reporter cell lines ("Cell Chip"). Ringerike T; Ullerås E; Völker R; Verlaan B; Eikeset A; Trzaska D; Adamczewska V; Olszewski M; Walczak-Drzewiecka A; Arkusz J; van Loveren H; Nilsson G; Lovik M; Dastych J; Vandebriel RJ Toxicology; 2005 Jan; 206(2):257-72. PubMed ID: 15588918 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates. Stubenrauch K; Wessels U; Lenz H J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787 [TBL] [Abstract][Full Text] [Related]
52. The selection of marmoset monkeys (Callithrix jacchus) in pharmaceutical toxicology. Smith D; Trennery P; Farningham D; Klapwijk J Lab Anim; 2001 Apr; 35(2):117-30. PubMed ID: 11315160 [TBL] [Abstract][Full Text] [Related]
53. Animal models of toxicology testing: the role of pigs. Helke KL; Swindle MM Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):127-39. PubMed ID: 23216131 [TBL] [Abstract][Full Text] [Related]
54. Comparative lifespan and healthspan of nonhuman primate species common to biomedical research. Huber HF; Ainsworth HC; Quillen E; Salmon A; Ross C; Azhar AD; Bales K; Basso MA; Coleman K; Colman R; Darusman HS; Hopkins W; Hotchkiss CE; Jorgensen M; Kavanagh K; Li C; Mattison JA; Nathanielsz PW; Saputro S; Scorpio D; Sosa PM; Vallender E; Wang Y; Zeiss C; Shively C; Cox LA bioRxiv; 2024 Aug; ():. PubMed ID: 39131309 [TBL] [Abstract][Full Text] [Related]
55. The enhanced pre- and postnatal development study for monoclonal antibodies. Weinbauer GF; Luft J; Fuchs A Methods Mol Biol; 2013; 947():185-200. PubMed ID: 23138905 [TBL] [Abstract][Full Text] [Related]
56. Immune modulator studies in primates: the utility of flow cytometry and immunohistochemistry in the identification and characterization of immunotoxicity. Lappin PB; Black LE Toxicol Pathol; 2003; 31 Suppl():111-8. PubMed ID: 12597438 [TBL] [Abstract][Full Text] [Related]
58. Feasibility of human trials to assess developmental immunotoxicity, and some comparison with data on New World monkeys. Neubert RT; Webb JR; Neubert D Hum Exp Toxicol; 2002; 21(9-10):543-67. PubMed ID: 12458914 [TBL] [Abstract][Full Text] [Related]
59. Preclinical models of multiple sclerosis in nonhuman primates. 't Hart BA; Jagessar SA; Kap YS; Brok HP Expert Rev Clin Immunol; 2007 Sep; 3(5):749-61. PubMed ID: 20477025 [TBL] [Abstract][Full Text] [Related]
60. Safety evaluation of biological drugs: what are toxicology studies in primates telling us? Baldrick P Regul Toxicol Pharmacol; 2011 Mar; 59(2):227-36. PubMed ID: 20937341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]